Assessment reveals potent antioxidant capacity and significant enzyme inhibition in Equisetum ramosissimum, indicating potential for oxidative stress and diabetes management.
This study provides a comprehensive investigation of the phytochemical composition, antioxidant capacity, and enzyme inhibition properties of Equisetum ramosissimum, a medicinal plant traditionally used in Turkey. The main aim was to characterize its bioactive compounds and evaluate their biological relevance using modern analytical techniques. Ethanolic extracts of the plant were analyzed by LC-MS/MS, enabling the identification and quantification of 13 phenolic compounds, including kaempferol (1458.11 µg/L), vanillic acid (1002.26 µg/L), and resveratrol (424.12 µg/L). Antioxidant activity was assessed through DPPH, ABTS, FRAP, and CUPRAC assays, where the extract demonstrated strong radical scavenging and metal reducing capacity. Enzyme inhibition studies revealed significant inhibitory effects on AChE, BChE, and α-glucosidase, with IC₅₀ values comparable to standard inhibitors. These findings indicate that E. ramosissimum is a rich source of phenolic compounds with strong antioxidants and enzyme inhibitory properties. The originality of this work lies in its systematic evaluation of Turkish E. ramosissimum populations, highlighting their potential as natural therapeutic agents for managing oxidative stress-related diseases, neurodegenerative disorders, and diabetes.
No takes yet. Share an insight, caveat, or question.
Emrah Dikici (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: